Clinical Trial Update: Study to Assess the Incidence of Hemolysis, Safety, and Efficacy of Tafenoquine (SB-252263, WR238605) Versus Primaquine in Subjects With Plasmodium Vivax Malaria [Phase 3]

View source ↗

Summary

Phase 3 clinical trial comparing tafenoquine to primaquine in Plasmodium vivax malaria to evaluate incidence of hemolysis, safety, and efficacy; results were po…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plasmodium Vivax Malaria

Drugs mentioned

• Primaquine (primaquine)
• Tafenoquine (tafenoquine)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Malaria, Vivax | Phase 3 | Status: COMPLETED | Results posted: 2018-05-16